PRESAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Presamine patents expire, and when can generic versions of Presamine launch?
Presamine is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in PRESAMINE is imipramine hydrochloride. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Presamine
A generic version of PRESAMINE was approved as imipramine hydrochloride by STRIDES PHARMA INTL on October 21st, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRESAMINE?
- What are the global sales for PRESAMINE?
- What is Average Wholesale Price for PRESAMINE?
Summary for PRESAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| Patent Applications: | 2,355 |
| DailyMed Link: | PRESAMINE at DailyMed |
US Patents and Regulatory Information for PRESAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | PRESAMINE | imipramine hydrochloride | TABLET;ORAL | 011836-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | PRESAMINE | imipramine hydrochloride | TABLET;ORAL | 011836-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | PRESAMINE | imipramine hydrochloride | TABLET;ORAL | 011836-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
